CH
GMAB icon

Cromwell Holdings’s Genmab GMAB Stock Holding History

Cromwell Holdings’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.6K Hold
1,077
– – 0.01% 548
2026
Q1 		$28.9K Sell
1,077
-454
-30% -$13.6K 0.02% 531
2025
Q4 		$47.2K Hold
1,531
– – 0.03% 471
2025
Q3 		$47K Buy
1,531
+883
+136% +$21.5K 0.03% 493
2025
Q2 		$13.4K Buy
+648
New +$13.3K 0.01% 582
2025
Q1 		– Sell
-2,876
Closed -$60K – 824
2024
Q4 		$60K Buy
2,876
+2,496
+657% +$54.8K 0.03% 407
2024
Q3 		$9.26K Hold
380
– – 0.01% 596
2024
Q2 		$9.55K Buy
+380
New +$10.8K 0.01% 595

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Cromwell Holdings's GMAB Position: Q2 2026 in Review

Cromwell Holdings held its Genmab (GMAB) position steady in Q2 2026 at 1,077 shares worth $29.6K. The position accounts for 0.01% of the portfolio, ranked #548.

Cromwell Holdings first reported a position in GMAB in Q2 2024 and has held it in 8 quarters since. The position peaked at $60K in Q4 2024. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Cromwell Holdings held 1,077 shares of Genmab worth $29.6K as of Q2 2026.
  • Cromwell Holdings left its Genmab share count unchanged in Q2 2026.
  • Genmab made up 0.01% of Cromwell Holdings's portfolio in Q2 2026, its #548 holding.
  • Cromwell Holdings first reported a position in Genmab in Q2 2024 and has held it in 8 quarters since.
  • Cromwell Holdings's Genmab position peaked at $60K in Q4 2024.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.